These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32973971)

  • 21. Sonidegib as a Locally Advanced Basal Cell Carcinoma Therapy in Real-life Clinical Setting: A National Multicentre Study.
    Moreno-Arrones OM; Béa-Ardebol S; Mayo-Martinez F; Pérez-Pastor G; Torres-Navarro I; Bonfill-Ortí M; Deza G; Ruiz-Salas V; Masferrer E; Feal C; Turrión-Merino L; Toll A; Yébenes M; Galiano-Mejías S; Jaka A; Ferrandiz-Pulido C; Florez A; Hernández-Hernández N; Fernández-de-Misa R; Rios-Buceta L; Sanmartin O
    Actas Dermosifiliogr; 2023; 114(7):565-571. PubMed ID: 37088285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FDA Approval Summary: Sonidegib for Locally Advanced Basal Cell Carcinoma.
    Casey D; Demko S; Shord S; Zhao H; Chen H; He K; Putman A; Helms W; Keegan P; Pazdur R
    Clin Cancer Res; 2017 May; 23(10):2377-2381. PubMed ID: 28073840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cemiplimab for locally advanced and metastatic basal cell carcinoma.
    Damsin T; Lebas E; Marchal N; Rorive A; Nikkels AF
    Expert Rev Anticancer Ther; 2022 Mar; 22(3):243-248. PubMed ID: 35175882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sonidegib in the Treatment of Locally Advanced Basal Cell Carcinoma.
    Sanmartín O; Llombart B; Carretero Hernández G; Flórez Menéndez Á; Botella-Estrada R; Herrera Ceballos E; Puig S
    Actas Dermosifiliogr (Engl Ed); 2021 Apr; 112(4):295-301. PubMed ID: 33197438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Efficacy of Sonidegib in Treating Locally Advanced Basal Cell Carcinoma Involving the Periocular Area.
    Villani A; Fabbrocini G; Micali G; Fornaro L; Potestio L; Scalvenzi M
    Dermatol Ther (Heidelb); 2023 Sep; 13(9):2121-2126. PubMed ID: 37477769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase I, multicenter, open-label, first-in-human, dose-escalation study of the oral smoothened inhibitor Sonidegib (LDE225) in patients with advanced solid tumors.
    Rodon J; Tawbi HA; Thomas AL; Stoller RG; Turtschi CP; Baselga J; Sarantopoulos J; Mahalingam D; Shou Y; Moles MA; Yang L; Granvil C; Hurh E; Rose KL; Amakye DD; Dummer R; Mita AC
    Clin Cancer Res; 2014 Apr; 20(7):1900-9. PubMed ID: 24523439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Sonidegib Following Dose Reduction and Treatment Interruption in Patients with Advanced Basal Cell Carcinoma During 42-Month BOLT Trial.
    Lewis K; Dummer R; Farberg AS; Guminski A; Squittieri N; Migden M
    Dermatol Ther (Heidelb); 2021 Dec; 11(6):2225-2234. PubMed ID: 34669179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sonidegib for the Treatment of Advanced Basal Cell Carcinoma.
    Brancaccio G; Pea F; Moscarella E; Argenziano G
    Front Oncol; 2020; 10():582866. PubMed ID: 33194718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experience with sonidegib in patients with advanced basal cell carcinoma: case reports.
    Puig S; Serra-Guillén C; Pérez-Pastor G; Martínez-Domenech Á; Fernández-de-Misa Cabrera R
    Drugs Context; 2022; 11():. PubMed ID: 35677182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The safety and efficacy of sonidegib for the treatment of locally advanced basal cell carcinoma.
    Collier NJ; Ali FR; Lear JT
    Expert Rev Anticancer Ther; 2016 Oct; 16(10):1011-8. PubMed ID: 27636236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical clearance of complex basal cell carcinoma in patients receiving sonidegib: A case series.
    Leow LJ; Teh N
    Dermatol Ther; 2022 Feb; 35(2):e15217. PubMed ID: 34816547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benefit-risk assessment of sonidegib and vismodegib in the treatment of locally advanced basal cell carcinoma.
    García Ruiz AJ; García-Agua Soler N; Herrera Acosta E; Zalaudek I; Malvehy J
    Drugs Context; 2022; 11():. PubMed ID: 35912002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hedgehog Pathway Inhibition.
    Sekulic A; Von Hoff D
    Cell; 2016 Feb; 164(5):831. PubMed ID: 26919418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vismodegib: an inhibitor of the Hedgehog signaling pathway in the treatment of basal cell carcinoma.
    Proctor AE; Thompson LA; O'Bryant CL
    Ann Pharmacother; 2014 Jan; 48(1):99-106. PubMed ID: 24259609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicenter Retrospective Andalusian Study of the Use of Sonidegib for the Treatment of Local Advanced Basal Cell Carcinoma in Real Clinical Practice.
    Ruiz-Villaverde R; Herrera-Acosta E; Ruiz de Casas A; Villegas-Romero IM; Moreno-Suárez FG; Vílchez-Márquez F; Galán-Gutiérrez M; Vázquez-Bayo MC; Cases-Mérida S; Almazán-Fernández FM
    J Clin Med; 2023 Aug; 12(17):. PubMed ID: 37685698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sonidegib, a novel smoothened inhibitor for the treatment of advanced basal cell carcinoma.
    Doan HQ; Silapunt S; Migden MR
    Onco Targets Ther; 2016; 9():5671-5678. PubMed ID: 27695345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sonidegib for the treatment of advanced basal cell carcinoma: a comprehensive review of sonidegib and the BOLT trial with 12-month update.
    Chen L; Silapunt S; Migden MR
    Future Oncol; 2016 Sep; 12(18):2095-105. PubMed ID: 27189494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma.
    Lacouture ME; Dréno B; Ascierto PA; Dummer R; Basset-Seguin N; Fife K; Ernst S; Licitra L; Neves RI; Peris K; Puig S; Sokolof J; Sekulic A; Hauschild A; Kunstfeld R
    Oncologist; 2016 Oct; 21(10):1218-1229. PubMed ID: 27511905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Investigator-Initiated Open-Label Trial of Sonidegib in Advanced Basal Cell Carcinoma Patients Resistant to Vismodegib.
    Danial C; Sarin KY; Oro AE; Chang AL
    Clin Cancer Res; 2016 Mar; 22(6):1325-9. PubMed ID: 26546616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sonidegib in the Treatment of Locally Advanced Basal Cell Carcinoma: a Retrospective Study.
    Herms F; Baroudjian B; Delyon J; Laly P; Tetu P; Lebbe C; Basset-Seguin N
    Acta Derm Venereol; 2022 May; 102():adv00740. PubMed ID: 35604234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.